e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pathogenesis of diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased cytokeratin-19 expression in fibrotic interstitial lung disease
M. Chorti, F. Drakopanagiotakis, N. Maouni, N. Trakas, E. P. Pierrakou, E. M. Antonogiannaki, M. Daimonakou, S. Legaki (Athens, Greece)
Source:
Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Session:
Pathogenesis of diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
4182
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Chorti, F. Drakopanagiotakis, N. Maouni, N. Trakas, E. P. Pierrakou, E. M. Antonogiannaki, M. Daimonakou, S. Legaki (Athens, Greece). Increased cytokeratin-19 expression in fibrotic interstitial lung disease. Eur Respir J 2010; 36: Suppl. 54, 4182
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
Does “UIPAF” really exist?
Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Related content which might interest you:
KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Increased CCL18 production in interstitial lung diseases is associated with fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004
A clinicopathological review of interstitial pneumonia with marked IgG
4
positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Circulating fibrocytes in interstitial lung disease
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Role of IL23 in the development of fibrotic interstitial lung disease
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
αVβ6 integrin expression in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Elevation of serum tumor markers in patients with interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs)
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Aquoaporin-1 expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004
Alveoscopy in diffuse interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 244s
Year: 2007
Differential gene expression of lung fibroblasts derived from UIP and NSIP patterns of interstitial lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept